Quarterly report pursuant to Section 13 or 15(d)

EQUITY

v3.24.1.u1
EQUITY
 3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Equity
Accumulated Other Comprehensive Income (Loss)
The following table presents changes in the components of AOCI, net of taxes, for the three months ended March 31, 2024:
Cash Flow Hedge  Foreign Currency Items Total
(in thousands)
Balance at December 31, 2023 $ 29,350  $ (1,900) $ 27,450 
Other comprehensive income before reclassifications
 8,369  4,729  13,098 
Amount reclassified from AOCI (4,730) —  (4,730)
Net other comprehensive income 3,639  4,729  8,368 
Balance at March 31, 2024 $ 32,989  $ 2,829  $ 35,818 
Earnings Per Share
Basic net income per common share is computed by dividing the net income available to common stockholders by the weighted average number of common shares outstanding during the period. The calculation of diluted net income per common share includes the effects of the assumed exercise of any outstanding stock options, the assumed vesting of shares of restricted and deferred stock awards and the assumed conversion of our convertible senior notes, where dilutive. For the three months ended March 31, 2024 and 2023 there were no reconciling items to the weighted average common shares outstanding in the calculation of diluted net loss per common share.
The following table shows securities excluded from the calculation of diluted net income per common share because such securities are anti-dilutive:
Three Months Ended
March 31,
2024 2023
Options to purchase shares of common stock 2,301,848  3,237,229 
Restricted stock and deferred stock—unvested 4,159,664  3,593,402 
Conversion shares related to the convertible senior notes 13,004,660  13,004,660 
Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding 19,466,172  19,835,291